Research output per year
Research output per year
Research activity per year
Experienced biotechnology executive, with demonstrated history as CEO, Chairman and Board member. Over twenty years as an executive in the biotechnology industry which include 12 years as President & CEO of Protalix Biotherapeutics, leading it to FDA drug approval (Elelyso for treating Gaucher Disease) and Wall Street listing (NYSE). Skilled in drug developmemt, privete and public market financing, FDA, GMP production and clinical trials. Strong business development and strategic planning professional. Ph.D. in Biochemistray & Molecular Biology from the Weizmann Institute of Science as well as an MBA from Bar Ilan university.
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
… → Jan 1996
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Comment/debate